1,054 filings
Page 5 of 53
144
Therapeutics OcuMension
5 Dec 23
Notice of proposed sale of securities
8:54am
424B5
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Prospectus supplement for primary offering
5:31pm
144/A
Nancy Lurker
4 Dec 23
Notice of proposed sale of securities (amended)
4:34pm
144
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Notice of proposed sale of securities
4:16pm
144
Michael Craig Pine
4 Dec 23
Notice of proposed sale of securities
4:15pm
144
Nancy Lurker
4 Dec 23
Notice of proposed sale of securities
3:39pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Other Events
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
9 Nov 23
Other Events
8:00am
10-Q
2023 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
3 Nov 23
3:47pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
1 Nov 23
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
EFFECT
EYPT
EyePoint Pharmaceuticals Inc
31 Oct 23
Notice of effectiveness
12:15am
CORRESP
EYPT
EyePoint Pharmaceuticals Inc
26 Oct 23
Correspondence with SEC
12:00am
UPLOAD
EYPT
EyePoint Pharmaceuticals Inc
25 Oct 23
Letter from SEC
12:00am
S-3
EYPT
EyePoint Pharmaceuticals Inc
Shelf registration
20 Oct 23
5:18pm
S-8
EYPT
EyePoint Pharmaceuticals Inc
20 Oct 23
Registration of securities for employees
5:15pm
4
Stuart Duty
17 Oct 23
EyePoint Pharmaceuticals / Stuart Duty ownership change
4:49pm
3
Stuart Duty
17 Oct 23
EyePoint Pharmaceuticals / Stuart Duty ownership change
4:48pm
4
George Elston
17 Oct 23
EyePoint Pharmaceuticals / George Elston ownership change
4:47pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
16 Oct 23
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
13 Sep 23
Other Events
7:06am